2161
vs
H
Hang Seng (Hong Kong)
2161
Over the past 12 months, Jbm (Healthcare) Ltd has outperformed Hang Seng (Hong Kong), delivering a return of +32% compared to the Hang Seng (Hong Kong)'s +21% growth.
Stocks Performance
2161 vs Hang Seng (Hong Kong)
Performance Gap
2161 vs Hang Seng (Hong Kong)
Performance By Year
2161 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jbm (Healthcare) Ltd
Glance View
JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 274 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.